IL6 and neoplasm: In this context, IL-6 detection has been demonstrated in point-of-care (POC) platforms for early disease (e.g., sepsis, cancer) diagnosis and prognosis [17,18], as well as in OoC models for monitoring inflammatory processes including tumor progression and therapeutic resistance [19,20].